Late de novo minimal change disease in a renal allograft.
Among the causes of the nephrotic syndrome in renal allografts, minimal change disease is a rarity with only few cases described in the medical literature. Most cases described have occurred early in the post-transplant course. There is no established treatment for the condition but prognosis is favorable. We describe a case of minimal change disease that developed 8 years after a successful transplantation of a renal allograft in a middle-aged woman. The nephrotic syndrome was accompanied by deterioration of allograft function. Treatment with mycophenolate mofetil was successful in inducing remission and stabilizing allograft function.
Madhan
Krishan K
KK
Renal Unit, Taranaki District Health Board, New Plymouth, New Zealand. krishan.madhan@gmail.com
Temple-Camp
Cynric R E
CR
D001706:Biopsy; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000601:surgery*; D007678:Kidney Glomerulus / Q000473:pathology; D016030:Kidney Transplantation / Q000473:pathology*; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D009402:Nephrosis, Lipoid / Q000097:blood / Q000188:drug therapy / Q000473:pathology*; D011355:Prodrugs; D012074:Remission Induction / Q000379:methods; D013997:Time Factors; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D011355:Prodrugs; D009173:Mycophenolic Acid